Global Prophylactic Human Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Prophylactic Human Vaccine market size was valued at US$ 180 million in 2023. With growing demand in downstream market, the Prophylactic Human Vaccine is forecast to a readjusted size of US$ 278.5 million by 2030 with a CAGR of 6.4% during review period.
The research report highlights the growth potential of the global Prophylactic Human Vaccine market. Prophylactic Human Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Prophylactic Human Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Prophylactic Human Vaccine market.
Vaccination in the body of a healthy person causes the person to produce antibodies and obtain specific immunity in the absence of disease. For example, BCG vaccination, smallpox vaccination and so on.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Prophylactic Human Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Prophylactic Human Vaccine market. It may include historical data, market segmentation by Type (e.g., Inactivated Vaccine, Attenuated Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Prophylactic Human Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Prophylactic Human Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Prophylactic Human Vaccine industry. This include advancements in Prophylactic Human Vaccine technology, Prophylactic Human Vaccine new entrants, Prophylactic Human Vaccine new investment, and other innovations that are shaping the future of Prophylactic Human Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Prophylactic Human Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Prophylactic Human Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Prophylactic Human Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Prophylactic Human Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Prophylactic Human Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Prophylactic Human Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Prophylactic Human Vaccine market.
Market Segmentation:
Prophylactic Human Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Prophylactic Human Vaccine market?
What factors are driving Prophylactic Human Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Prophylactic Human Vaccine market opportunities vary by end market size?
How does Prophylactic Human Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Prophylactic Human Vaccine market size was valued at US$ 180 million in 2023. With growing demand in downstream market, the Prophylactic Human Vaccine is forecast to a readjusted size of US$ 278.5 million by 2030 with a CAGR of 6.4% during review period.
The research report highlights the growth potential of the global Prophylactic Human Vaccine market. Prophylactic Human Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Prophylactic Human Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Prophylactic Human Vaccine market.
Vaccination in the body of a healthy person causes the person to produce antibodies and obtain specific immunity in the absence of disease. For example, BCG vaccination, smallpox vaccination and so on.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Prophylactic Human Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Prophylactic Human Vaccine market. It may include historical data, market segmentation by Type (e.g., Inactivated Vaccine, Attenuated Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Prophylactic Human Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Prophylactic Human Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Prophylactic Human Vaccine industry. This include advancements in Prophylactic Human Vaccine technology, Prophylactic Human Vaccine new entrants, Prophylactic Human Vaccine new investment, and other innovations that are shaping the future of Prophylactic Human Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Prophylactic Human Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Prophylactic Human Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Prophylactic Human Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Prophylactic Human Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Prophylactic Human Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Prophylactic Human Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Prophylactic Human Vaccine market.
Market Segmentation:
Prophylactic Human Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Inactivated Vaccine
- Attenuated Vaccine
- Others
- Hospital
- Scientific Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Biovac
- McKesson Medical
- Merck
- Merial
- Zoetis
- Sanofi
What is the 10-year outlook for the global Prophylactic Human Vaccine market?
What factors are driving Prophylactic Human Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Prophylactic Human Vaccine market opportunities vary by end market size?
How does Prophylactic Human Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prophylactic Human Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Prophylactic Human Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Prophylactic Human Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Prophylactic Human Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Attenuated Vaccine
2.2.3 Others
2.3 Prophylactic Human Vaccine Sales by Type
2.3.1 Global Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Prophylactic Human Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Prophylactic Human Vaccine Sale Price by Type (2019-2024)
2.4 Prophylactic Human Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Scientific Research
2.4.3 Others
2.5 Prophylactic Human Vaccine Sales by Application
2.5.1 Global Prophylactic Human Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Prophylactic Human Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Prophylactic Human Vaccine Sale Price by Application (2019-2024)
3 GLOBAL PROPHYLACTIC HUMAN VACCINE BY COMPANY
3.1 Global Prophylactic Human Vaccine Breakdown Data by Company
3.1.1 Global Prophylactic Human Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Prophylactic Human Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Prophylactic Human Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Prophylactic Human Vaccine Revenue by Company (2019-2024)
3.2.2 Global Prophylactic Human Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Prophylactic Human Vaccine Sale Price by Company
3.4 Key Manufacturers Prophylactic Human Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prophylactic Human Vaccine Product Location Distribution
3.4.2 Players Prophylactic Human Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PROPHYLACTIC HUMAN VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Prophylactic Human Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Prophylactic Human Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Prophylactic Human Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Prophylactic Human Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Prophylactic Human Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Prophylactic Human Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Prophylactic Human Vaccine Sales Growth
4.4 APAC Prophylactic Human Vaccine Sales Growth
4.5 Europe Prophylactic Human Vaccine Sales Growth
4.6 Middle East & Africa Prophylactic Human Vaccine Sales Growth
5 AMERICAS
5.1 Americas Prophylactic Human Vaccine Sales by Country
5.1.1 Americas Prophylactic Human Vaccine Sales by Country (2019-2024)
5.1.2 Americas Prophylactic Human Vaccine Revenue by Country (2019-2024)
5.2 Americas Prophylactic Human Vaccine Sales by Type
5.3 Americas Prophylactic Human Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prophylactic Human Vaccine Sales by Region
6.1.1 APAC Prophylactic Human Vaccine Sales by Region (2019-2024)
6.1.2 APAC Prophylactic Human Vaccine Revenue by Region (2019-2024)
6.2 APAC Prophylactic Human Vaccine Sales by Type
6.3 APAC Prophylactic Human Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Prophylactic Human Vaccine by Country
7.1.1 Europe Prophylactic Human Vaccine Sales by Country (2019-2024)
7.1.2 Europe Prophylactic Human Vaccine Revenue by Country (2019-2024)
7.2 Europe Prophylactic Human Vaccine Sales by Type
7.3 Europe Prophylactic Human Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prophylactic Human Vaccine by Country
8.1.1 Middle East & Africa Prophylactic Human Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Prophylactic Human Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Prophylactic Human Vaccine Sales by Type
8.3 Middle East & Africa Prophylactic Human Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prophylactic Human Vaccine
10.3 Manufacturing Process Analysis of Prophylactic Human Vaccine
10.4 Industry Chain Structure of Prophylactic Human Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prophylactic Human Vaccine Distributors
11.3 Prophylactic Human Vaccine Customer
12 WORLD FORECAST REVIEW FOR PROPHYLACTIC HUMAN VACCINE BY GEOGRAPHIC REGION
12.1 Global Prophylactic Human Vaccine Market Size Forecast by Region
12.1.1 Global Prophylactic Human Vaccine Forecast by Region (2025-2030)
12.1.2 Global Prophylactic Human Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Prophylactic Human Vaccine Forecast by Type
12.7 Global Prophylactic Human Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Prophylactic Human Vaccine Product Portfolios and Specifications
13.1.3 GSK Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Biovac
13.2.1 Biovac Company Information
13.2.2 Biovac Prophylactic Human Vaccine Product Portfolios and Specifications
13.2.3 Biovac Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Biovac Main Business Overview
13.2.5 Biovac Latest Developments
13.3 McKesson Medical
13.3.1 McKesson Medical Company Information
13.3.2 McKesson Medical Prophylactic Human Vaccine Product Portfolios and Specifications
13.3.3 McKesson Medical Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 McKesson Medical Main Business Overview
13.3.5 McKesson Medical Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Prophylactic Human Vaccine Product Portfolios and Specifications
13.4.3 Merck Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Merial
13.5.1 Merial Company Information
13.5.2 Merial Prophylactic Human Vaccine Product Portfolios and Specifications
13.5.3 Merial Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Merial Main Business Overview
13.5.5 Merial Latest Developments
13.6 Zoetis
13.6.1 Zoetis Company Information
13.6.2 Zoetis Prophylactic Human Vaccine Product Portfolios and Specifications
13.6.3 Zoetis Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Zoetis Main Business Overview
13.6.5 Zoetis Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Prophylactic Human Vaccine Product Portfolios and Specifications
13.7.3 Sanofi Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prophylactic Human Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Prophylactic Human Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Prophylactic Human Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Prophylactic Human Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Attenuated Vaccine
2.2.3 Others
2.3 Prophylactic Human Vaccine Sales by Type
2.3.1 Global Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Prophylactic Human Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Prophylactic Human Vaccine Sale Price by Type (2019-2024)
2.4 Prophylactic Human Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Scientific Research
2.4.3 Others
2.5 Prophylactic Human Vaccine Sales by Application
2.5.1 Global Prophylactic Human Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Prophylactic Human Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Prophylactic Human Vaccine Sale Price by Application (2019-2024)
3 GLOBAL PROPHYLACTIC HUMAN VACCINE BY COMPANY
3.1 Global Prophylactic Human Vaccine Breakdown Data by Company
3.1.1 Global Prophylactic Human Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Prophylactic Human Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Prophylactic Human Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Prophylactic Human Vaccine Revenue by Company (2019-2024)
3.2.2 Global Prophylactic Human Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Prophylactic Human Vaccine Sale Price by Company
3.4 Key Manufacturers Prophylactic Human Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prophylactic Human Vaccine Product Location Distribution
3.4.2 Players Prophylactic Human Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PROPHYLACTIC HUMAN VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Prophylactic Human Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Prophylactic Human Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Prophylactic Human Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Prophylactic Human Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Prophylactic Human Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Prophylactic Human Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Prophylactic Human Vaccine Sales Growth
4.4 APAC Prophylactic Human Vaccine Sales Growth
4.5 Europe Prophylactic Human Vaccine Sales Growth
4.6 Middle East & Africa Prophylactic Human Vaccine Sales Growth
5 AMERICAS
5.1 Americas Prophylactic Human Vaccine Sales by Country
5.1.1 Americas Prophylactic Human Vaccine Sales by Country (2019-2024)
5.1.2 Americas Prophylactic Human Vaccine Revenue by Country (2019-2024)
5.2 Americas Prophylactic Human Vaccine Sales by Type
5.3 Americas Prophylactic Human Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prophylactic Human Vaccine Sales by Region
6.1.1 APAC Prophylactic Human Vaccine Sales by Region (2019-2024)
6.1.2 APAC Prophylactic Human Vaccine Revenue by Region (2019-2024)
6.2 APAC Prophylactic Human Vaccine Sales by Type
6.3 APAC Prophylactic Human Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Prophylactic Human Vaccine by Country
7.1.1 Europe Prophylactic Human Vaccine Sales by Country (2019-2024)
7.1.2 Europe Prophylactic Human Vaccine Revenue by Country (2019-2024)
7.2 Europe Prophylactic Human Vaccine Sales by Type
7.3 Europe Prophylactic Human Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prophylactic Human Vaccine by Country
8.1.1 Middle East & Africa Prophylactic Human Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Prophylactic Human Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Prophylactic Human Vaccine Sales by Type
8.3 Middle East & Africa Prophylactic Human Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prophylactic Human Vaccine
10.3 Manufacturing Process Analysis of Prophylactic Human Vaccine
10.4 Industry Chain Structure of Prophylactic Human Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prophylactic Human Vaccine Distributors
11.3 Prophylactic Human Vaccine Customer
12 WORLD FORECAST REVIEW FOR PROPHYLACTIC HUMAN VACCINE BY GEOGRAPHIC REGION
12.1 Global Prophylactic Human Vaccine Market Size Forecast by Region
12.1.1 Global Prophylactic Human Vaccine Forecast by Region (2025-2030)
12.1.2 Global Prophylactic Human Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Prophylactic Human Vaccine Forecast by Type
12.7 Global Prophylactic Human Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Prophylactic Human Vaccine Product Portfolios and Specifications
13.1.3 GSK Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Biovac
13.2.1 Biovac Company Information
13.2.2 Biovac Prophylactic Human Vaccine Product Portfolios and Specifications
13.2.3 Biovac Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Biovac Main Business Overview
13.2.5 Biovac Latest Developments
13.3 McKesson Medical
13.3.1 McKesson Medical Company Information
13.3.2 McKesson Medical Prophylactic Human Vaccine Product Portfolios and Specifications
13.3.3 McKesson Medical Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 McKesson Medical Main Business Overview
13.3.5 McKesson Medical Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Prophylactic Human Vaccine Product Portfolios and Specifications
13.4.3 Merck Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Merial
13.5.1 Merial Company Information
13.5.2 Merial Prophylactic Human Vaccine Product Portfolios and Specifications
13.5.3 Merial Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Merial Main Business Overview
13.5.5 Merial Latest Developments
13.6 Zoetis
13.6.1 Zoetis Company Information
13.6.2 Zoetis Prophylactic Human Vaccine Product Portfolios and Specifications
13.6.3 Zoetis Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Zoetis Main Business Overview
13.6.5 Zoetis Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Prophylactic Human Vaccine Product Portfolios and Specifications
13.7.3 Sanofi Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Prophylactic Human Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Prophylactic Human Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Attenuated Vaccine
Table 5. Major Players of Others
Table 6. Global Prophylactic Human Vaccine Sales by Type (2019-2024) & (K Units)
Table 7. Global Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global Prophylactic Human Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global Prophylactic Human Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global Prophylactic Human Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Prophylactic Human Vaccine Sales by Application (2019-2024) & (K Units)
Table 12. Global Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Table 13. Global Prophylactic Human Vaccine Revenue by Application (2019-2024)
Table 14. Global Prophylactic Human Vaccine Revenue Market Share by Application (2019-2024)
Table 15. Global Prophylactic Human Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Prophylactic Human Vaccine Sales by Company (2019-2024) & (K Units)
Table 17. Global Prophylactic Human Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global Prophylactic Human Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Prophylactic Human Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global Prophylactic Human Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Prophylactic Human Vaccine Producing Area Distribution and Sales Area
Table 22. Players Prophylactic Human Vaccine Products Offered
Table 23. Prophylactic Human Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Prophylactic Human Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Prophylactic Human Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global Prophylactic Human Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Prophylactic Human Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Prophylactic Human Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Prophylactic Human Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global Prophylactic Human Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Prophylactic Human Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Prophylactic Human Vaccine Sales by Country (2019-2024) & (K Units)
Table 35. Americas Prophylactic Human Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas Prophylactic Human Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Prophylactic Human Vaccine Revenue Market Share by Country (2019-2024)
Table 38. Americas Prophylactic Human Vaccine Sales by Type (2019-2024) & (K Units)
Table 39. Americas Prophylactic Human Vaccine Sales by Application (2019-2024) & (K Units)
Table 40. APAC Prophylactic Human Vaccine Sales by Region (2019-2024) & (K Units)
Table 41. APAC Prophylactic Human Vaccine Sales Market Share by Region (2019-2024)
Table 42. APAC Prophylactic Human Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Prophylactic Human Vaccine Revenue Market Share by Region (2019-2024)
Table 44. APAC Prophylactic Human Vaccine Sales by Type (2019-2024) & (K Units)
Table 45. APAC Prophylactic Human Vaccine Sales by Application (2019-2024) & (K Units)
Table 46. Europe Prophylactic Human Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Europe Prophylactic Human Vaccine Sales Market Share by Country (2019-2024)
Table 48. Europe Prophylactic Human Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Prophylactic Human Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Europe Prophylactic Human Vaccine Sales by Type (2019-2024) & (K Units)
Table 51. Europe Prophylactic Human Vaccine Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Prophylactic Human Vaccine Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Prophylactic Human Vaccine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Prophylactic Human Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Prophylactic Human Vaccine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Prophylactic Human Vaccine Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Prophylactic Human Vaccine Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Prophylactic Human Vaccine
Table 59. Key Market Challenges & Risks of Prophylactic Human Vaccine
Table 60. Key Industry Trends of Prophylactic Human Vaccine
Table 61. Prophylactic Human Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Prophylactic Human Vaccine Distributors List
Table 64. Prophylactic Human Vaccine Customer List
Table 65. Global Prophylactic Human Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Prophylactic Human Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Prophylactic Human Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Prophylactic Human Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Prophylactic Human Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Prophylactic Human Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Prophylactic Human Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Prophylactic Human Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Prophylactic Human Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Prophylactic Human Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Prophylactic Human Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Prophylactic Human Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Prophylactic Human Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Prophylactic Human Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. GSK Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. GSK Prophylactic Human Vaccine Product Portfolios and Specifications
Table 81. GSK Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. GSK Main Business
Table 83. GSK Latest Developments
Table 84. Biovac Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Biovac Prophylactic Human Vaccine Product Portfolios and Specifications
Table 86. Biovac Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Biovac Main Business
Table 88. Biovac Latest Developments
Table 89. McKesson Medical Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. McKesson Medical Prophylactic Human Vaccine Product Portfolios and Specifications
Table 91. McKesson Medical Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. McKesson Medical Main Business
Table 93. McKesson Medical Latest Developments
Table 94. Merck Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Merck Prophylactic Human Vaccine Product Portfolios and Specifications
Table 96. Merck Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Merck Main Business
Table 98. Merck Latest Developments
Table 99. Merial Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Merial Prophylactic Human Vaccine Product Portfolios and Specifications
Table 101. Merial Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Merial Main Business
Table 103. Merial Latest Developments
Table 104. Zoetis Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Zoetis Prophylactic Human Vaccine Product Portfolios and Specifications
Table 106. Zoetis Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Zoetis Main Business
Table 108. Zoetis Latest Developments
Table 109. Sanofi Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Sanofi Prophylactic Human Vaccine Product Portfolios and Specifications
Table 111. Sanofi Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Sanofi Main Business
Table 113. Sanofi Latest Developments
.
Table 1. Prophylactic Human Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Prophylactic Human Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Attenuated Vaccine
Table 5. Major Players of Others
Table 6. Global Prophylactic Human Vaccine Sales by Type (2019-2024) & (K Units)
Table 7. Global Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global Prophylactic Human Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global Prophylactic Human Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global Prophylactic Human Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Prophylactic Human Vaccine Sales by Application (2019-2024) & (K Units)
Table 12. Global Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Table 13. Global Prophylactic Human Vaccine Revenue by Application (2019-2024)
Table 14. Global Prophylactic Human Vaccine Revenue Market Share by Application (2019-2024)
Table 15. Global Prophylactic Human Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Prophylactic Human Vaccine Sales by Company (2019-2024) & (K Units)
Table 17. Global Prophylactic Human Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global Prophylactic Human Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Prophylactic Human Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global Prophylactic Human Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Prophylactic Human Vaccine Producing Area Distribution and Sales Area
Table 22. Players Prophylactic Human Vaccine Products Offered
Table 23. Prophylactic Human Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Prophylactic Human Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Prophylactic Human Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global Prophylactic Human Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Prophylactic Human Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Prophylactic Human Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Prophylactic Human Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global Prophylactic Human Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Prophylactic Human Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Prophylactic Human Vaccine Sales by Country (2019-2024) & (K Units)
Table 35. Americas Prophylactic Human Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas Prophylactic Human Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Prophylactic Human Vaccine Revenue Market Share by Country (2019-2024)
Table 38. Americas Prophylactic Human Vaccine Sales by Type (2019-2024) & (K Units)
Table 39. Americas Prophylactic Human Vaccine Sales by Application (2019-2024) & (K Units)
Table 40. APAC Prophylactic Human Vaccine Sales by Region (2019-2024) & (K Units)
Table 41. APAC Prophylactic Human Vaccine Sales Market Share by Region (2019-2024)
Table 42. APAC Prophylactic Human Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Prophylactic Human Vaccine Revenue Market Share by Region (2019-2024)
Table 44. APAC Prophylactic Human Vaccine Sales by Type (2019-2024) & (K Units)
Table 45. APAC Prophylactic Human Vaccine Sales by Application (2019-2024) & (K Units)
Table 46. Europe Prophylactic Human Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Europe Prophylactic Human Vaccine Sales Market Share by Country (2019-2024)
Table 48. Europe Prophylactic Human Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Prophylactic Human Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Europe Prophylactic Human Vaccine Sales by Type (2019-2024) & (K Units)
Table 51. Europe Prophylactic Human Vaccine Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Prophylactic Human Vaccine Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Prophylactic Human Vaccine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Prophylactic Human Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Prophylactic Human Vaccine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Prophylactic Human Vaccine Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Prophylactic Human Vaccine Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Prophylactic Human Vaccine
Table 59. Key Market Challenges & Risks of Prophylactic Human Vaccine
Table 60. Key Industry Trends of Prophylactic Human Vaccine
Table 61. Prophylactic Human Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Prophylactic Human Vaccine Distributors List
Table 64. Prophylactic Human Vaccine Customer List
Table 65. Global Prophylactic Human Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Prophylactic Human Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Prophylactic Human Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Prophylactic Human Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Prophylactic Human Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Prophylactic Human Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Prophylactic Human Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Prophylactic Human Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Prophylactic Human Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Prophylactic Human Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Prophylactic Human Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Prophylactic Human Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Prophylactic Human Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Prophylactic Human Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. GSK Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. GSK Prophylactic Human Vaccine Product Portfolios and Specifications
Table 81. GSK Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. GSK Main Business
Table 83. GSK Latest Developments
Table 84. Biovac Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Biovac Prophylactic Human Vaccine Product Portfolios and Specifications
Table 86. Biovac Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Biovac Main Business
Table 88. Biovac Latest Developments
Table 89. McKesson Medical Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. McKesson Medical Prophylactic Human Vaccine Product Portfolios and Specifications
Table 91. McKesson Medical Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. McKesson Medical Main Business
Table 93. McKesson Medical Latest Developments
Table 94. Merck Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Merck Prophylactic Human Vaccine Product Portfolios and Specifications
Table 96. Merck Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Merck Main Business
Table 98. Merck Latest Developments
Table 99. Merial Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Merial Prophylactic Human Vaccine Product Portfolios and Specifications
Table 101. Merial Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Merial Main Business
Table 103. Merial Latest Developments
Table 104. Zoetis Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Zoetis Prophylactic Human Vaccine Product Portfolios and Specifications
Table 106. Zoetis Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Zoetis Main Business
Table 108. Zoetis Latest Developments
Table 109. Sanofi Basic Information, Prophylactic Human Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Sanofi Prophylactic Human Vaccine Product Portfolios and Specifications
Table 111. Sanofi Prophylactic Human Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Sanofi Main Business
Table 113. Sanofi Latest Developments
LIST OF FIGURES
.
Figure 1. Picture of Prophylactic Human Vaccine
Figure 2. Prophylactic Human Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prophylactic Human Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Prophylactic Human Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Prophylactic Human Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Inactivated Vaccine
Figure 10. Product Picture of Attenuated Vaccine
Figure 11. Product Picture of Others
Figure 12. Global Prophylactic Human Vaccine Sales Market Share by Type in 2023
Figure 13. Global Prophylactic Human Vaccine Revenue Market Share by Type (2019-2024)
Figure 14. Prophylactic Human Vaccine Consumed in Hospital
Figure 15. Global Prophylactic Human Vaccine Market: Hospital (2019-2024) & (K Units)
Figure 16. Prophylactic Human Vaccine Consumed in Scientific Research
Figure 17. Global Prophylactic Human Vaccine Market: Scientific Research (2019-2024) & (K Units)
Figure 18. Prophylactic Human Vaccine Consumed in Others
Figure 19. Global Prophylactic Human Vaccine Market: Others (2019-2024) & (K Units)
Figure 20. Global Prophylactic Human Vaccine Sales Market Share by Application (2023)
Figure 21. Global Prophylactic Human Vaccine Revenue Market Share by Application in 2023
Figure 22. Prophylactic Human Vaccine Sales Market by Company in 2023 (K Units)
Figure 23. Global Prophylactic Human Vaccine Sales Market Share by Company in 2023
Figure 24. Prophylactic Human Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Prophylactic Human Vaccine Revenue Market Share by Company in 2023
Figure 26. Global Prophylactic Human Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Prophylactic Human Vaccine Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Prophylactic Human Vaccine Sales 2019-2024 (K Units)
Figure 29. Americas Prophylactic Human Vaccine Revenue 2019-2024 ($ Millions)
Figure 30. APAC Prophylactic Human Vaccine Sales 2019-2024 (K Units)
Figure 31. APAC Prophylactic Human Vaccine Revenue 2019-2024 ($ Millions)
Figure 32. Europe Prophylactic Human Vaccine Sales 2019-2024 (K Units)
Figure 33. Europe Prophylactic Human Vaccine Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Prophylactic Human Vaccine Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Prophylactic Human Vaccine Revenue 2019-2024 ($ Millions)
Figure 36. Americas Prophylactic Human Vaccine Sales Market Share by Country in 2023
Figure 37. Americas Prophylactic Human Vaccine Revenue Market Share by Country in 2023
Figure 38. Americas Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
Figure 39. Americas Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Figure 40. United States Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Prophylactic Human Vaccine Sales Market Share by Region in 2023
Figure 45. APAC Prophylactic Human Vaccine Revenue Market Share by Regions in 2023
Figure 46. APAC Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
Figure 47. APAC Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Figure 48. China Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Prophylactic Human Vaccine Sales Market Share by Country in 2023
Figure 56. Europe Prophylactic Human Vaccine Revenue Market Share by Country in 2023
Figure 57. Europe Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
Figure 58. Europe Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Figure 59. Germany Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Prophylactic Human Vaccine Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Prophylactic Human Vaccine Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Figure 68. Egypt Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Prophylactic Human Vaccine in 2023
Figure 74. Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure 75. Industry Chain Structure of Prophylactic Human Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Prophylactic Human Vaccine Sales Market Forecast by Region (2025-2030)
Figure 78. Global Prophylactic Human Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Prophylactic Human Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Prophylactic Human Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Prophylactic Human Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Prophylactic Human Vaccine Revenue Market Share Forecast by Application (2025-2030)
.
Figure 1. Picture of Prophylactic Human Vaccine
Figure 2. Prophylactic Human Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prophylactic Human Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Prophylactic Human Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Prophylactic Human Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Inactivated Vaccine
Figure 10. Product Picture of Attenuated Vaccine
Figure 11. Product Picture of Others
Figure 12. Global Prophylactic Human Vaccine Sales Market Share by Type in 2023
Figure 13. Global Prophylactic Human Vaccine Revenue Market Share by Type (2019-2024)
Figure 14. Prophylactic Human Vaccine Consumed in Hospital
Figure 15. Global Prophylactic Human Vaccine Market: Hospital (2019-2024) & (K Units)
Figure 16. Prophylactic Human Vaccine Consumed in Scientific Research
Figure 17. Global Prophylactic Human Vaccine Market: Scientific Research (2019-2024) & (K Units)
Figure 18. Prophylactic Human Vaccine Consumed in Others
Figure 19. Global Prophylactic Human Vaccine Market: Others (2019-2024) & (K Units)
Figure 20. Global Prophylactic Human Vaccine Sales Market Share by Application (2023)
Figure 21. Global Prophylactic Human Vaccine Revenue Market Share by Application in 2023
Figure 22. Prophylactic Human Vaccine Sales Market by Company in 2023 (K Units)
Figure 23. Global Prophylactic Human Vaccine Sales Market Share by Company in 2023
Figure 24. Prophylactic Human Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Prophylactic Human Vaccine Revenue Market Share by Company in 2023
Figure 26. Global Prophylactic Human Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Prophylactic Human Vaccine Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Prophylactic Human Vaccine Sales 2019-2024 (K Units)
Figure 29. Americas Prophylactic Human Vaccine Revenue 2019-2024 ($ Millions)
Figure 30. APAC Prophylactic Human Vaccine Sales 2019-2024 (K Units)
Figure 31. APAC Prophylactic Human Vaccine Revenue 2019-2024 ($ Millions)
Figure 32. Europe Prophylactic Human Vaccine Sales 2019-2024 (K Units)
Figure 33. Europe Prophylactic Human Vaccine Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Prophylactic Human Vaccine Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Prophylactic Human Vaccine Revenue 2019-2024 ($ Millions)
Figure 36. Americas Prophylactic Human Vaccine Sales Market Share by Country in 2023
Figure 37. Americas Prophylactic Human Vaccine Revenue Market Share by Country in 2023
Figure 38. Americas Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
Figure 39. Americas Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Figure 40. United States Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Prophylactic Human Vaccine Sales Market Share by Region in 2023
Figure 45. APAC Prophylactic Human Vaccine Revenue Market Share by Regions in 2023
Figure 46. APAC Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
Figure 47. APAC Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Figure 48. China Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Prophylactic Human Vaccine Sales Market Share by Country in 2023
Figure 56. Europe Prophylactic Human Vaccine Revenue Market Share by Country in 2023
Figure 57. Europe Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
Figure 58. Europe Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Figure 59. Germany Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Prophylactic Human Vaccine Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Prophylactic Human Vaccine Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Prophylactic Human Vaccine Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Prophylactic Human Vaccine Sales Market Share by Application (2019-2024)
Figure 68. Egypt Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Prophylactic Human Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Prophylactic Human Vaccine in 2023
Figure 74. Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure 75. Industry Chain Structure of Prophylactic Human Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Prophylactic Human Vaccine Sales Market Forecast by Region (2025-2030)
Figure 78. Global Prophylactic Human Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Prophylactic Human Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Prophylactic Human Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Prophylactic Human Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Prophylactic Human Vaccine Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Endodontic Handpieces Market Growth 2024-2030
US$ 3,660.00
September 2024
97 pages
Global Geldanamycin Market Growth 2024-2030
US$ 3,660.00
June 2024
150 pages
Global OTC Consumer Health Products (Powder Form) Market Growth 2025-2031
US$ 3,660.00
December 2025
86 pages
Global Functional Service Provider (FSP) Clinical Research Organization Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
90 pages
Global Distal Radius Plates Market Growth 2025-2031
US$ 3,660.00
April 2025
113 pages
